This compound is a derivative of ansamitocin, a macrolide antibiotic, and is used primarily as a pharmaceutical intermediate in manufacturing processes.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 72902-38-6
Ansamitomicin p-3
pharmaceutical intermediate
Ansamitocin P-3
pharmaceutical raw material
Maytansinol
pharmaceutical intermediate
3-[2-[(Phenylmethyl)amino]ethyl]-2,4(1H,3H)quinazolinedione
pharmaceutical intermediate
2-Hydroxy-3-methoxy-3,3-diphenylpropanoic acid methyl ester
pharmaceutical intermediate
4,6-Dichloro-1-indanone
pharmaceutical intermediate
Pyridine-d5
pharmaceutical intermediate
Alpha-Amino-3-chlorophenylacetic acid
pharmaceutical intermediate
[(1S,2R,3S,5S,6S,16Z,18Z,20R,21S)-11-chloro-12,21-dihydroxy-20-methoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-yl] 2-methylpropanoate
YQVKSZNVVCIETH-AJWAOHEYSA-N
C[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(/CC3=CC(=C(C(=C3)O)Cl)N(C(=O)C[C@@H]([C@]4([C@H]1O4)C)OC(=O)C(C)C)C)\C)OC)(NC(=O)O2)O